Simon Mark 4
4 · Cabaletta Bio, Inc. · Filed Oct 18, 2022
Insider Transaction Report
Form 4
Simon Mark
Director
Transactions
- Purchase
Common Stock
2022-10-18$0.98/sh+118,000$115,286→ 136,144 total - Purchase
Common Stock
2022-10-18$0.98/sh+7,000$6,835→ 7,000 total(indirect: By Spouse)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $0.9315 to $0.99, inclusive. The reporting person has provided to the Issuer, and undertakes to provide any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $0.9375 to $0.9899, inclusive.